121 results
424B3
INM
InMed Pharmaceuticals Inc.
27 Jun 24
Prospectus supplement
6:27pm
that are bioidentical to those found in nature.
Since our acquisition of Biogen Sciences Inc., a privately held British Columbia pharmaceutical company focused … with our employees are good.
We are committed to growing our business over the long-term. As a result of the competitive nature of the industry
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc.
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
, warranties or representations of any kind, written or oral, express or implied, including any relating to the nature of the position or its duration … opportunity to review this arbitration provision, inquire about the nature and extent of the costs of arbitration and seek legal advice.
Initial Here: NJ
8-K
EX-10.2
5n0qf6qu
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.1
h3mrxnk6 rfdcihp
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
EX-10.2
95yre 9nm5afzw
13 Dec 22
InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor
3:47pm
8-K
9ji5jvdnrer1ha2i
12 Dec 22
Changes in Registrant's Certifying Accountant
8:14pm
D
iow2h pyahbcr6
5 Dec 22
$6.00 mm in equity / options, sold $6.00 mm, 2 investors
7:25pm
8-K
EX-10.1
nqmmwem2cmkmove 15fz
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
8-K
EX-10.2
88d4c
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
424B3
gmrrl pzfh8h9tdv8h
19 Oct 22
Prospectus supplement
6:10am